Article Details
Retrieved on: 2022-05-28 18:31:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
WHAT IS KNOWN AND OBJECTIVE: Anti-spike monoclonal antibodies (MAB) including bamlanivimab (BAM) and bamlanivimab/etesevimab (BAM/E) have shown ...
Article found on: www.docwirenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here